Isoniazid metabolism has been well studied in part because a polymorphism in N‐acetyltransferase 2 (NAT2 polymorphism) was detected in the 1950s when isoniazid was first used to treat tuberculosis (TB), with acetylation shown to be a key step in its metabolism [15]. This evidence concerns the gene NAT2 and tuberculosis.